Related Experiment Video
Updated: Jul 19, 2026
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation
M D Linden1, P Whittaker, A L Frelinger
1Center for Platelet Function Studies, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Insights
Ischemic preconditioning (PC) reduces platelet activation and aggregation, improving blood flow during thrombosis. This study provides direct evidence that PC favorably down-regulates platelet reactivity, offering new insights into its protective effects.
Area of Science:
- Cardiovascular Research
- Hematology
- Ischemic Physiology
Background:
- Ischemic preconditioning (PC) is known to limit infarct size and improve arterial patency in recurrent thrombosis models.
- The mechanism for improved patency was hypothesized to involve PC-induced attenuation of platelet-mediated thrombosis.
- Direct evidence for PC's effect on platelet reactivity was previously lacking.
Purpose of the Study:
- To investigate whether ischemic preconditioning (PC) attenuates molecular markers of platelet activation and aggregation.
- To provide direct evidence for the impact of PC on platelet function.
Main Methods:
- Anesthetized dogs underwent either 10 minutes of ischemic preconditioning (PC) followed by 10 minutes of reperfusion or a time-matched control period.
- Recurrent coronary thrombosis was induced via injury and stenosis of the left anterior descending coronary artery.
- Coronary flow was monitored for 3 hours, and molecular indices of platelet activation-aggregation were quantified using whole blood flow cytometry.
Main Results:
- The PC group maintained better coronary patency (53% of baseline) compared to controls (23% of baseline) after thrombosis induction.
- PC significantly down-regulated platelet-fibrinogen binding and neutrophil-platelet aggregate formation.
- A trend towards reduced platelet P-selectin expression was observed in the PC group.
Conclusions:
- These findings provide novel, direct evidence that ischemic preconditioning attenuates molecular indices of platelet activation and aggregation.
- PC favorably modulates platelet reactivity, contributing to improved arterial patency during thrombosis.
- The study supports the concept that PC directly impacts platelet function to confer protection.
Background:
Previous studies have shown that ischemic preconditioning (PC) not only limits infarct size, but also improves arterial patency in models of recurrent thrombosis. We hypothesize that this enhanced patency is presumably because of a PC-induced attenuation of platelet-mediated thrombosis. However, there is, at present, no direct evidence that PC acts on the platelets per se and favorably down-regulates platelet reactivity.
Objectives:
Our goal was to test the concept that PC ischemia attenuates molecular indices of platelet activation-aggregation.
Methods:
Anesthetized dogs were randomly assigned to receive 10 min of PC ischemia followed by 10 min of reperfusion or a time-matched control period. Spontaneous recurrent coronary thrombosis was then initiated in all dogs by injury + stenosis of the left anterior descending coronary artery. Coronary flow was monitored for 3 h poststenosis, and molecular indices of platelet activation-aggregation were quantified by whole blood flow cytometry.
Results:
Coronary patency was, as expected, better-maintained following injury + stenosis in the PC group vs. controls (53% +/- 5%* vs. 23% +/- 5% of baseline flow, respectively; *P < 0.05). Moreover, PC was accompanied by: (i) a significant down-regulation of platelet-fibrinogen binding and formation of neutrophil-platelet aggregates (112% +/- 14%* vs. 177% +/- 21% and 107% +/- 8%* vs. 155% +/- 19% of baseline values in PC vs. control groups); and (ii) a trend towards a reduction in platelet P-selectin expression (148% +/- 12% vs. 190% +/- 21% of baseline; *P < 0.05 and P = 0.09 vs. control).
Conclusion:
These data provide novel, direct evidence in support of the concept that ischemic PC attenuates molecular indices of platelet activation-aggregation.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:30Peripheral Artery Disease I: Introduction